首页 > 最新文献

Eplasty最新文献

英文 中文
Measuring Biomechanical Properties Using a Noninvasive Myoton Device for Lymphedema Detection and Tracking: A Pilot Study. 使用无创Myoton装置测量淋巴水肿检测和跟踪的生物力学特性:一项试点研究。
Pub Date : 2022-11-10 eCollection Date: 2022-01-01
Gabriella E Glassman, Laura Dellalana, Eric R Tkaczyk, Isaac Manzanera Esteve, Joyce Yongxu Huang, Austin Cronin, J Randall Patrinely, Shervin Etemad, Patrick E Assi, Shelia Ridner, Antonio Jorge Forte, Salam Al Kassis, Galen Perdikis

Background: Improved techniques for lymphedema detection and monitoring of disease progression are needed. This study aims to use the noninvasive MyotonPRO Device to detect differences in biomechanical skin characteristics in patients with breast cancer-related lymphedema (BCRL).

Methods: The handheld Myoton device was used to measure skin parameters including dynamic skin stiffness, oscillation frequency (tone), mechanical stress relaxation time, and creep in 11 women diagnosed with BCRL. Seven anatomical sites were measured bilaterally for each participant. The average values in the affected arms were compared with those in the contralateral unaffected arms.

Results: Among the 11 female participants with unilateral BCRL Stages 0 to II, the combined averages for dynamic skin stiffness and frequency measurements were decreased in the affected arms when compared with those for the contralateral control arms (ratio < 1). The median ratio of stiffness (affected to unaffected control arm) was 0.91 (interquartile range [IQR] 0.78-1.03) while frequency was 0.94 (IQR 0.89-1.0). Skin relaxation time and creep averages were increased in the affected arms. The relaxation time median ratio (affected to unaffected control arm) was 1.07 (IQR 1.02-1.14) and the median ratio of creep was 1.06 (IQR 1.03-1.16).

Conclusions: This study suggests the Myoton can detect differences in skin biomechanical parameters of the affected and unaffected arms in patients with BCRL. Larger studies are needed to draw strong conclusions.

背景:需要改进淋巴水肿检测和疾病进展监测技术。本研究旨在使用无创MyotonPRO设备检测乳腺癌相关淋巴水肿(BCRL)患者生物力学皮肤特征的差异。方法:采用手持式Myoton仪测量11例诊断为BCRL的女性皮肤动态刚度、振动频率(音调)、机械应力松弛时间、蠕变等皮肤参数。对每个参与者的7个解剖部位进行双侧测量。将受影响手臂的平均值与对侧未受影响手臂的平均值进行比较。结果:在11名患有单侧BCRL 0至II期的女性参与者中,与对侧对照组相比,受影响手臂的动态皮肤刚度和频率测量的联合平均值降低(比值< 1)。(受影响与未受影响的对照组)的中位刚度比为0.91(四分位间距[IQR] 0.78-1.03),而频率为0.94 (IQR 0.89-1.0)。患臂皮肤松弛时间和蠕变平均值增加。松弛时间中位数比(受影响组与未受影响组)为1.07 (IQR 1.02-1.14),蠕变中位数比为1.06 (IQR 1.03-1.16)。结论:本研究提示Myoton可以检测BCRL患者患肢和未患肢皮肤生物力学参数的差异。需要更大规模的研究才能得出强有力的结论。
{"title":"Measuring Biomechanical Properties Using a Noninvasive Myoton Device for Lymphedema Detection and Tracking: A Pilot Study.","authors":"Gabriella E Glassman, Laura Dellalana, Eric R Tkaczyk, Isaac Manzanera Esteve, Joyce Yongxu Huang, Austin Cronin, J Randall Patrinely, Shervin Etemad, Patrick E Assi, Shelia Ridner, Antonio Jorge Forte, Salam Al Kassis, Galen Perdikis","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Improved techniques for lymphedema detection and monitoring of disease progression are needed. This study aims to use the noninvasive MyotonPRO Device to detect differences in biomechanical skin characteristics in patients with breast cancer-related lymphedema (BCRL).</p><p><strong>Methods: </strong>The handheld Myoton device was used to measure skin parameters including dynamic skin stiffness, oscillation frequency (tone), mechanical stress relaxation time, and creep in 11 women diagnosed with BCRL. Seven anatomical sites were measured bilaterally for each participant. The average values in the affected arms were compared with those in the contralateral unaffected arms.</p><p><strong>Results: </strong>Among the 11 female participants with unilateral BCRL Stages 0 to II, the combined averages for dynamic skin stiffness and frequency measurements were decreased in the affected arms when compared with those for the contralateral control arms (ratio < 1). The median ratio of stiffness (affected to unaffected control arm) was 0.91 (interquartile range [IQR] 0.78-1.03) while frequency was 0.94 (IQR 0.89-1.0). Skin relaxation time and creep averages were increased in the affected arms. The relaxation time median ratio (affected to unaffected control arm) was 1.07 (IQR 1.02-1.14) and the median ratio of creep was 1.06 (IQR 1.03-1.16).</p><p><strong>Conclusions: </strong>This study suggests the Myoton can detect differences in skin biomechanical parameters of the affected and unaffected arms in patients with BCRL. Larger studies are needed to draw strong conclusions.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":"22 ","pages":"e54"},"PeriodicalIF":0.0,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664374/pdf/eplasty-22-e54.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9345528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Group A Streptococcal Rapid Antigen Detection Test: A Clinical Study to Evaluate the Reproducibility Using Human Wound Samples. A组链球菌快速抗原检测试验:评价人体伤口标本重复性的临床研究。
Pub Date : 2022-11-09 eCollection Date: 2022-01-01
Itaru Tsuge, Miho Matsui, Tomofumi Nakamura, Keisuke Watanabe, Eiichi Sawaragi, Hiroki Yamanaka, Motoki Katsube, Michiharu Sakamoto, Susumu Saito, Naoki Morimoto

Background: The early diagnosis of necrotizing soft tissue infection (NSTI) caused by group A streptococcus (GAS) for performing debridement surgery is key to the patient survival. In 1996, the diversional use of a GAS-rapid antigen detection test (RADT) for pharyngitis was reported, quickly spreading as a clinically useful method. However, no clinical study has evaluated the reliability of RADT by using wound samples. This is the first study using clinical wound samples to examine the reproducibility between GAS-RADT and wound culture.

Methods: Patients in whom wound culture samples were clinically necessary were included in this study. Two samples were obtained simultaneously: one for isolation of bacteria as wound culture and the other for GAS-RADT, with written informed consent. The reproducibility between GAS-RADT and wound culture was statistically evaluated by Cohen's kappa coefficient.

Results: One hundred samples from 94 patients were collected from 2020 to 2021. Two samples were GAS-positive on wound culture, and both were RADT-positive (positive reproducibility: 100%). Ninety-eight samples were GAS-negative on wound culture; of these, 97 were RADT-negative (negative reproducibility: 99%). Cohen's kappa coefficient was 0.80, indicating excellent agreement beyond chance. None of the bacteria showed cross-reactional influences. The only discrepant case (RADT-positive and wound culture-negative) was attributed to the administration of antibiotics for 2 days before the sampling.

Conclusions: The reproducibility between GAS-RADT and wound culture was statistically excellent, underscoring the reliability of GAS-RADT for wounds.

背景:A群链球菌(GAS)致坏死性软组织感染(NSTI)的早期诊断和清创手术是影响患者生存的关键。1996年,一种气体快速抗原检测法(GAS-rapid antigen detection test, RADT)被报道用于咽炎,作为一种临床有用的方法迅速传播开来。然而,尚无临床研究通过使用伤口样本来评估RADT的可靠性。这是第一个使用临床伤口样本来检验GAS-RADT和伤口培养之间的可重复性的研究。方法:选取临床需要创面培养标本的患者为研究对象。同时获得两份样本:一份用于分离细菌作为伤口培养,另一份用于GAS-RADT,并获得书面知情同意。采用Cohen’s kappa系数对GAS-RADT与创面培养的重复性进行统计学评价。结果:2020 - 2021年共采集94例患者100份样本。两份样本伤口培养均为gas阳性,radt阳性(阳性重复性100%)。98例伤口培养gas阴性;其中97例为radt阴性(负重复性为99%)。Cohen的kappa系数为0.80,表明非常吻合。没有一种细菌显示出交叉反应的影响。唯一的差异病例(radt阳性和伤口培养阴性)归因于取样前2天使用抗生素。结论:GAS-RADT与伤口培养之间的重复性在统计学上是很好的,强调了GAS-RADT用于伤口的可靠性。
{"title":"Group A Streptococcal Rapid Antigen Detection Test: A Clinical Study to Evaluate the Reproducibility Using Human Wound Samples.","authors":"Itaru Tsuge,&nbsp;Miho Matsui,&nbsp;Tomofumi Nakamura,&nbsp;Keisuke Watanabe,&nbsp;Eiichi Sawaragi,&nbsp;Hiroki Yamanaka,&nbsp;Motoki Katsube,&nbsp;Michiharu Sakamoto,&nbsp;Susumu Saito,&nbsp;Naoki Morimoto","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The early diagnosis of necrotizing soft tissue infection (NSTI) caused by group A streptococcus (GAS) for performing debridement surgery is key to the patient survival. In 1996, the diversional use of a GAS-rapid antigen detection test (RADT) for pharyngitis was reported, quickly spreading as a clinically useful method. However, no clinical study has evaluated the reliability of RADT by using wound samples. This is the first study using clinical wound samples to examine the reproducibility between GAS-RADT and wound culture.</p><p><strong>Methods: </strong>Patients in whom wound culture samples were clinically necessary were included in this study. Two samples were obtained simultaneously: one for isolation of bacteria as wound culture and the other for GAS-RADT, with written informed consent. The reproducibility between GAS-RADT and wound culture was statistically evaluated by Cohen's kappa coefficient.</p><p><strong>Results: </strong>One hundred samples from 94 patients were collected from 2020 to 2021. Two samples were GAS-positive on wound culture, and both were RADT-positive (positive reproducibility: 100%). Ninety-eight samples were GAS-negative on wound culture; of these, 97 were RADT-negative (negative reproducibility: 99%). Cohen's kappa coefficient was 0.80, indicating excellent agreement beyond chance. None of the bacteria showed cross-reactional influences. The only discrepant case (RADT-positive and wound culture-negative) was attributed to the administration of antibiotics for 2 days before the sampling.</p><p><strong>Conclusions: </strong>The reproducibility between GAS-RADT and wound culture was statistically excellent, underscoring the reliability of GAS-RADT for wounds.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e53"},"PeriodicalIF":0.0,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664372/pdf/eplasty-22-e53.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40710310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Tissue Apposition and Seroma Prevention in an Ovine Model of Surgical Dead Space Using a Novel Air-Purged Vacuum Closure System. 利用新型空气净化真空封闭系统评估绵羊手术死腔模型的组织附着和血清肿预防。
Pub Date : 2022-10-12 eCollection Date: 2022-01-01
Isaac Tt Mason, Hamish J Rose, Sarah F Williamson, Alister T Jowsey, Sean J Gorman, Henry D Chittock, Christopher Ch Wong, Anish J Dheda, Samuel B Turner, Young Eun Park, Tarek Kollmetz, Jenny M Sonis, J Lacy Kamm, Barnaby Ch May

Background: Postoperative complications associated with seroma formation resulting from surgical dead space continue to present a challenge in modern surgery. There is an unmet need for new technologies that address surgical dead space as well as prevent seroma formation and associated downstream postoperative complications.

Methods: The novel implantable tissue apposition and drainage system ENIVO was developed and tested in a bilateral ovine external abdominal oblique (EAO) resection model of surgical dead space. The ENIVO system is a portable powered pump and wound interface featuring air-purged vacuum closure (APVC) that delivers a sustained level of vacuum pressure (80 and 100 mmHg) to the treatment site with an intermittent burst of sterile filtered air through the implanted wound interface. Seroma area, seroma volume, and drain migration were assessed at postoperative days 7 and 14, and all animals were euthanized at day 28 with gross assessment of treatment efficacy including the presence of residual seroma and tissue apposition.

Results: The bilateral model created relatively uniform defects of ~120 cm2 following excision of ~30 to 50 g of EAO muscle. Median seroma area of ENIVO-treated defects was statistically smaller than standard of care (SoC)-treated defects at days 7 and 14. Median seroma volume at 14 days was significantly reduced in ENIVO-treated defects relative to SoC-treated defects [1.3 (IQR 0.0-79.5) mL and 188.5 (IQR 27.6-342.9) mL, respectively]. At postoperative day 28, 40% (n = 4/10) of SoC defects showed a residual seroma, whereas in contrast, none of the ENIVO-treated defects showed signs of a residual seroma. Median tissue apposition scoring was higher in the ENIVO treatment group [3 (IQR 3-3)] compared with the SoC group [3 (IQR 0-3)].

Conclusions: The ENIVO system represents a new approach to dead space management and seroma prevention and was shown to outperform a SoC surgical drain in a challenging large defect model of surgical dead space management and seroma prevention.

背景:手术死腔导致的血肿并发症在现代外科手术中仍然是一个挑战。对于解决手术死腔以及预防血清肿形成和相关的术后并发症的新技术的需求尚未得到满足。方法:在双侧羊腹外斜(EAO)手术死腔切除模型上,研制了一种新型的可植入组织旁置引流系统ENIVO。ENIVO系统是一种便携式动力泵和伤口界面,具有空气净化真空封闭(APVC)功能,可通过植入伤口界面间歇爆发无菌过滤空气,向治疗部位提供持续的真空压力(80和100 mmHg)。在术后第7天和第14天评估血肿面积、血肿体积和引流液迁移,并在第28天对所有动物实施安乐死,并对治疗效果进行总体评估,包括是否存在残留血肿和组织附着。结果:双侧模型在切除~30 ~ 50 g EAO肌后形成了~120 cm2的相对均匀的缺损。在第7天和第14天,enivo治疗缺陷的中位血肿面积在统计学上小于标准护理(SoC)治疗的缺陷。与soc处理的缺陷相比,enivo处理的缺陷14天的中位血肿体积显著减少[分别为1.3 (IQR 0.0-79.5) mL和188.5 (IQR 27.6-342.9) mL]。术后28天,40% (n = 4/10)的SoC缺陷显示残留血肿,而相比之下,所有经enivo治疗的缺陷均未显示残留血肿迹象。ENIVO治疗组的中位组织旁位评分[3 (IQR 3-3)]高于SoC组[3 (IQR 0-3)]。结论:ENIVO系统代表了一种新的死亡空间管理和血肿预防方法,在具有挑战性的手术死亡空间管理和血肿预防的大缺陷模型中,ENIVO系统被证明优于SoC手术引流。
{"title":"Evaluation of Tissue Apposition and Seroma Prevention in an Ovine Model of Surgical Dead Space Using a Novel Air-Purged Vacuum Closure System.","authors":"Isaac Tt Mason,&nbsp;Hamish J Rose,&nbsp;Sarah F Williamson,&nbsp;Alister T Jowsey,&nbsp;Sean J Gorman,&nbsp;Henry D Chittock,&nbsp;Christopher Ch Wong,&nbsp;Anish J Dheda,&nbsp;Samuel B Turner,&nbsp;Young Eun Park,&nbsp;Tarek Kollmetz,&nbsp;Jenny M Sonis,&nbsp;J Lacy Kamm,&nbsp;Barnaby Ch May","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Postoperative complications associated with seroma formation resulting from surgical dead space continue to present a challenge in modern surgery. There is an unmet need for new technologies that address surgical dead space as well as prevent seroma formation and associated downstream postoperative complications.</p><p><strong>Methods: </strong>The novel implantable tissue apposition and drainage system ENIVO was developed and tested in a bilateral ovine external abdominal oblique (EAO) resection model of surgical dead space. The ENIVO system is a portable powered pump and wound interface featuring air-purged vacuum closure (APVC) that delivers a sustained level of vacuum pressure (80 and 100 mmHg) to the treatment site with an intermittent burst of sterile filtered air through the implanted wound interface. Seroma area, seroma volume, and drain migration were assessed at postoperative days 7 and 14, and all animals were euthanized at day 28 with gross assessment of treatment efficacy including the presence of residual seroma and tissue apposition.</p><p><strong>Results: </strong>The bilateral model created relatively uniform defects of ~120 cm<sup>2</sup> following excision of ~30 to 50 g of EAO muscle. Median seroma area of ENIVO-treated defects was statistically smaller than standard of care (SoC)-treated defects at days 7 and 14. Median seroma volume at 14 days was significantly reduced in ENIVO-treated defects relative to SoC-treated defects [1.3 (IQR 0.0-79.5) mL and 188.5 (IQR 27.6-342.9) mL, respectively]. At postoperative day 28, 40% (n = 4/10) of SoC defects showed a residual seroma, whereas in contrast, none of the ENIVO-treated defects showed signs of a residual seroma. Median tissue apposition scoring was higher in the ENIVO treatment group [3 (IQR 3-3)] compared with the SoC group [3 (IQR 0-3)].</p><p><strong>Conclusions: </strong>The ENIVO system represents a new approach to dead space management and seroma prevention and was shown to outperform a SoC surgical drain in a challenging large defect model of surgical dead space management and seroma prevention.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e46"},"PeriodicalIF":0.0,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643872/pdf/eplasty-22-e46.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40504714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report and Literature Review of Giant Cutaneous Malignant Melanoma: What's Keeping Patients Away? 巨大皮肤恶性黑色素瘤病例报告及文献综述:是什么让患者远离?
Pub Date : 2022-09-23 eCollection Date: 2022-01-01
Jamie A Mawhinney, Adrien Yvon, Shahid Masood

Background. Giant cutaneous malignant melanoma (MM) is a term that has previously been used to define lesions that are at least 10 cm in diameter or 48 mm in thickness. Such tumours are rare. There is no substantial body of evidence considering why patients may delay presentation with MM until they reach this size. This case report presents one of the largest cases of giant cutaneous MM to date and the first in the literature to show excellent response to adjuvant immunotherapy. The patient was treated successfully and remains alive and well 12 months following initial surgery. A review of the literature discussing giant MM identified a significant need for education on the importance of seeking medical attention in order to prevent advanced disease, especially for vulnerable individuals.

背景。巨大皮肤恶性黑色素瘤(MM)是一个术语,以前用于定义直径至少10厘米或厚度至少48毫米的病变。这种肿瘤很少见。没有大量的证据表明为什么MM患者会延迟出现,直到他们达到这个大小。本病例报告是迄今为止最大的巨大皮肤MM病例之一,也是文献中第一个显示对辅助免疫治疗有良好反应的病例。患者治疗成功,术后12个月仍然存活。对讨论巨型MM的文献进行了回顾,发现有必要对寻求医疗照顾的重要性进行教育,以预防晚期疾病,特别是对易受伤害的个体。
{"title":"Case Report and Literature Review of Giant Cutaneous Malignant Melanoma: What's Keeping Patients Away?","authors":"Jamie A Mawhinney,&nbsp;Adrien Yvon,&nbsp;Shahid Masood","doi":"","DOIUrl":"","url":null,"abstract":"<p><p><b>Background.</b> Giant cutaneous malignant melanoma (MM) is a term that has previously been used to define lesions that are at least 10 cm in diameter or 48 mm in thickness. Such tumours are rare. There is no substantial body of evidence considering why patients may delay presentation with MM until they reach this size. This case report presents one of the largest cases of giant cutaneous MM to date and the first in the literature to show excellent response to adjuvant immunotherapy. The patient was treated successfully and remains alive and well 12 months following initial surgery. A review of the literature discussing giant MM identified a significant need for education on the importance of seeking medical attention in order to prevent advanced disease, especially for vulnerable individuals.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e45"},"PeriodicalIF":0.0,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516761/pdf/eplasty-22-e45.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33496444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One Size Does Not Fit All; Patient Preference for Breast Reconstruction. 一种尺码不适合所有人;患者对乳房再造的偏好。
Pub Date : 2022-09-21 eCollection Date: 2022-01-01
Shreya Raman, Lauren E Powell, Emily S Andersen, Lauren C Nigro

Background: A myriad of patient education modalities for breast reconstruction exist, although the optimal tools for patient education remain undetermined. The aim of this study is to determine patient preferences for breast reconstruction education modalities based on demographic variables.

Methods: A prospective observational study at a tertiary care university health system was conducted between November 2020 and May 2021. A questionnaire was administered to breast reconstruction patients to collect information on demographics, research sources used before the initial appointment, and preferred education modalities. Differences based on age were analyzed using an independent samples t test, whereas a Fisher exact test was used to analyze differences based on ethnicity and education level. Statistical significance was defined as P < .05.

Results: The most preferred patient education tools overall were books/written materials and videos. Younger patients were significantly more likely than older patients to have referenced additional physician sources (P = .0174) and to seek out information on the institution's website (P = .0465). Those with a college degree were significantly more likely to have performed research prior to the initial appointment (P = .0206). White patients were significantly more likely than nonwhite patients to talk to friends/family as a research source (P = .0150).

Conclusions: Regardless of age, education, or ethnicity, most patients prefer books/written materials and video presentations for education on breast reconstruction. Providers should strive to include written and video options to meet the needs of this diverse patient population.

背景:存在无数的乳房重建患者教育模式,尽管患者教育的最佳工具仍未确定。本研究的目的是根据人口统计学变量确定患者对乳房重建教育方式的偏好。方法:在2020年11月至2021年5月期间在三级保健大学卫生系统进行了一项前瞻性观察研究。对乳房重建患者进行问卷调查,以收集人口统计学信息、初次预约前使用的研究来源和首选的教育方式。基于年龄的差异使用独立样本t检验进行分析,而基于种族和教育水平的差异使用Fisher精确检验进行分析。统计学意义定义为P < 0.05。结果:总体而言,最受欢迎的患者教育工具是书籍/书面材料和视频。与老年患者相比,年轻患者更有可能参考其他医生资料(P = 0.0174),并在机构网站上查找信息(P = 0.0465)。那些拥有大学学位的人更有可能在最初的任命之前进行研究(P = 0.0206)。白人患者比非白人患者更有可能将朋友/家人作为研究来源(P = .0150)。结论:无论年龄、教育程度或种族,大多数患者更喜欢书籍/书面材料和视频演示进行乳房再造教育。提供者应努力包括书面和视频选项,以满足这一不同的患者群体的需要。
{"title":"One Size Does Not Fit All; Patient Preference for Breast Reconstruction.","authors":"Shreya Raman,&nbsp;Lauren E Powell,&nbsp;Emily S Andersen,&nbsp;Lauren C Nigro","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>A myriad of patient education modalities for breast reconstruction exist, although the optimal tools for patient education remain undetermined. The aim of this study is to determine patient preferences for breast reconstruction education modalities based on demographic variables.</p><p><strong>Methods: </strong>A prospective observational study at a tertiary care university health system was conducted between November 2020 and May 2021. A questionnaire was administered to breast reconstruction patients to collect information on demographics, research sources used before the initial appointment, and preferred education modalities. Differences based on age were analyzed using an independent samples <i>t</i> test, whereas a Fisher exact test was used to analyze differences based on ethnicity and education level. Statistical significance was defined as <i>P</i> < .05.</p><p><strong>Results: </strong>The most preferred patient education tools overall were books/written materials and videos. Younger patients were significantly more likely than older patients to have referenced additional physician sources (<i>P</i> = .0174) and to seek out information on the institution's website (<i>P</i> = .0465). Those with a college degree were significantly more likely to have performed research prior to the initial appointment (<i>P</i> = .0206). White patients were significantly more likely than nonwhite patients to talk to friends/family as a research source (<i>P</i> = .0150).</p><p><strong>Conclusions: </strong>Regardless of age, education, or ethnicity, most patients prefer books/written materials and video presentations for education on breast reconstruction. Providers should strive to include written and video options to meet the needs of this diverse patient population.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e44"},"PeriodicalIF":0.0,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516762/pdf/eplasty-22-e44.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33496445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Rectus Femoris Muscle Flap in Patients With Absent Profunda Femoris Vascular Flow. 股直肌瓣在股深静脉血流缺失患者中的应用。
Pub Date : 2022-09-15 eCollection Date: 2022-01-01
Graham M Grogan, Katherine C Benedict, Ian C Hoppe

Background: The rectus femoris (RF) muscle flap is an excellent choice for soft tissue coverage of complex wounds of the groin because of its reliable vascular anatomy and sufficient bulk allowing coverage of vascular anastomoses. The muscle receives its blood supply from the descending branch of the lateral femoral circumflex artery (dLFCA), which originates from the profunda femoris artery (PFA) in the proximal thigh. This case series reports 3 patients on whom pedicled RF muscle flaps were performed successfully despite known occlusion of the PFA preoperatively.

Methods: All 3 patients had a history of peripheral vascular disease (PVD) and underwent femoral-popliteal bypass. This was complicated by pseudoaneurysm in 2 patients and exposure of the polytetrafluorethylene graft in the third patient. Computed tomography angiography (CTA) or traditional angiography was obtained for each patient, showing occlusion of the PFA. After adequate debridement and confirming flow through the pedicle, vascular graft coverage at the groin was performed using a pedicled RF muscle flap, followed by split thickness skin grafting (n = 2) or primary skin closure (n = 1).

Results: The 3 patients included in this report had successful coverage of exposed vascular bypass grafts in the groin utilizing pedicled RF muscle flaps despite known occlusion of the PFA preoperatively. Follow-up at 3 months postoperatively showed healthy flaps with well-healed overlying skin graft or closure for all patients.

Conclusions: The pedicled RF muscle flap may be successfully used for coverage of complex groin wounds in patients with occlusion of the PFA. This flap is useful in complex groin wounds related to vascular interventions, particularly when other local options have been exhausted. This case report presents 3 successful cases of groin wound coverage using pedicled RF muscle flap despite known preoperative occlusion of the PFA.

背景:股直肌皮瓣是腹股沟复杂伤口软组织覆盖的最佳选择,因为其可靠的血管解剖结构和足够的体积允许血管吻合口的覆盖。该肌肉的血液供应来自股旋外侧动脉(dLFCA)的降支,它起源于大腿近端的股深动脉(PFA)。本病例系列报告了3例患者,尽管术前已知PFA闭塞,但带蒂射频肌瓣仍成功实施。方法:3例患者均有外周血管疾病(PVD)病史,均行股腘动脉搭桥术。2例患者并发假性动脉瘤,第三例患者暴露聚四氟乙烯移植物。每位患者均行计算机断层血管造影(CTA)或传统血管造影,显示PFA闭塞。在充分清创并确认血流通过椎弓根后,使用带蒂射频肌瓣覆盖腹股沟血管移植,随后进行分厚皮肤移植(n = 2)或原发性皮肤闭合(n = 1)。结果:本报告中包括的3例患者,尽管术前已知PFA闭塞,但利用带蒂射频肌瓣成功覆盖了腹股沟暴露的血管旁路移植。术后3个月随访显示所有患者皮瓣健康,复盖皮肤愈合良好或闭合。结论:带蒂射频肌瓣可成功地覆盖PFA闭塞患者的复杂腹股沟伤口。该皮瓣用于与血管介入相关的复杂腹股沟伤口,特别是当其他局部选择已经用尽时。本病例报告提出了3例使用带蒂射频肌瓣覆盖腹股沟伤口的成功病例,尽管术前已知PFA闭塞。
{"title":"Use of Rectus Femoris Muscle Flap in Patients With Absent Profunda Femoris Vascular Flow.","authors":"Graham M Grogan,&nbsp;Katherine C Benedict,&nbsp;Ian C Hoppe","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The rectus femoris (RF) muscle flap is an excellent choice for soft tissue coverage of complex wounds of the groin because of its reliable vascular anatomy and sufficient bulk allowing coverage of vascular anastomoses. The muscle receives its blood supply from the descending branch of the lateral femoral circumflex artery (dLFCA), which originates from the profunda femoris artery (PFA) in the proximal thigh. This case series reports 3 patients on whom pedicled RF muscle flaps were performed successfully despite known occlusion of the PFA preoperatively.</p><p><strong>Methods: </strong>All 3 patients had a history of peripheral vascular disease (PVD) and underwent femoral-popliteal bypass. This was complicated by pseudoaneurysm in 2 patients and exposure of the polytetrafluorethylene graft in the third patient. Computed tomography angiography (CTA) or traditional angiography was obtained for each patient, showing occlusion of the PFA. After adequate debridement and confirming flow through the pedicle, vascular graft coverage at the groin was performed using a pedicled RF muscle flap, followed by split thickness skin grafting (n = 2) or primary skin closure (n = 1).</p><p><strong>Results: </strong>The 3 patients included in this report had successful coverage of exposed vascular bypass grafts in the groin utilizing pedicled RF muscle flaps despite known occlusion of the PFA preoperatively. Follow-up at 3 months postoperatively showed healthy flaps with well-healed overlying skin graft or closure for all patients.</p><p><strong>Conclusions: </strong>The pedicled RF muscle flap may be successfully used for coverage of complex groin wounds in patients with occlusion of the PFA. This flap is useful in complex groin wounds related to vascular interventions, particularly when other local options have been exhausted. This case report presents 3 successful cases of groin wound coverage using pedicled RF muscle flap despite known preoperative occlusion of the PFA.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e42"},"PeriodicalIF":0.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516764/pdf/eplasty-22-e42.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33516714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-Vivo Evaluation of a Reinforced Ovine Biologic for Plastic and Reconstructive Procedures in a Non-human Primate Model of Soft Tissue Repair. 在非人类灵长类动物软组织修复模型中,一种增强的羊生物制品用于整形和重建程序的体内评估。
Pub Date : 2022-09-14 eCollection Date: 2022-01-01
Neal Overbeck, Amy Beierschmitt, Barnaby Ch May, Shijie Qi, Jennifer Koch

Background: Biologic matrices are used in plastic and reconstructive surgical procedures to aid in the kinetics of soft tissue repair and promote functional tissue formation. The human acellular dermal matrix AlloDerm is widely used; however, it is offered at a relatively high cost, and its dermal composition may not provide an ideal remodeling scaffold. OviTex Plastic and Reconstructive Surgery (PRS) Resorbable and Permanent are reinforced biologic matrices engineered with layers of ovine forestomach matrix embroidered with small amounts of polymer to optimize biophysical performance. This study compared the healing outcomes of these matrices in a non-human primate model of soft tissue repair.

Methods: Animals were implanted with test articles in surgically created full-thickness midline abdominal wall defects and evaluated macroscopically and histologically at 2, 4, 12, and 24 weeks.

Results: Both OviTex PRS Permanent and Resorbable matrices exhibited earlier host cell infiltration, neovascularization, and collagen deposition and also fully remodeled into the host tissue by 12 weeks post implantation. AlloDerm had less host cell infiltration and neovascularization at early time points and never fully integrated into the surrounding host tissue. There was no statistical difference in overall inflammation between AlloDerm and either OviTex PRS product at any time point, despite small amounts of polymer reinforcement in OviTex products.

Conclusions: In a primate soft tissue repair model, OviTex PRS Permanent and Resorbable matrices performed comparably with the leading human acellular dermal matrix. OviTex PRS Permanent and Resorbable are less expensive than alternatives like AlloDerm and may promote faster host cell proliferation and functional remodeling in some soft tissue repair applications.

背景:生物基质用于整形和重建外科手术,以帮助软组织修复动力学和促进功能性组织形成。人脱细胞真皮基质AlloDerm应用广泛;然而,它的成本相对较高,其真皮成分可能无法提供理想的重塑支架。OviTex塑料和重建手术(PRS)可吸收和永久是强化的生物基质,由绣有少量聚合物的绵羊前胃基质层工程化,以优化生物物理性能。本研究比较了这些基质在非人灵长类动物软组织修复模型中的愈合结果。方法:将实验品植入动物手术制造的全层腹壁中线缺损,并在2、4、12和24周进行宏观和组织学评估。结果:OviTex PRS永久基质和可吸收基质均表现出较早的宿主细胞浸润、新生血管形成和胶原沉积,并在植入后12周完全重塑为宿主组织。异体真皮早期宿主细胞浸润和新生血管形成较少,从未完全融入周围宿主组织。在任何时间点,AlloDerm和OviTex PRS产品之间的总体炎症没有统计学差异,尽管OviTex产品中含有少量聚合物增强剂。结论:在灵长类动物软组织修复模型中,OviTex PRS永久和可吸收基质与主要的人类脱细胞真皮基质表现相当。OviTex PRS Permanent和可吸收材料比AlloDerm等替代品更便宜,并且在一些软组织修复应用中可能促进宿主细胞更快的增殖和功能重塑。
{"title":"In-Vivo Evaluation of a Reinforced Ovine Biologic for Plastic and Reconstructive Procedures in a Non-human Primate Model of Soft Tissue Repair.","authors":"Neal Overbeck,&nbsp;Amy Beierschmitt,&nbsp;Barnaby Ch May,&nbsp;Shijie Qi,&nbsp;Jennifer Koch","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Biologic matrices are used in plastic and reconstructive surgical procedures to aid in the kinetics of soft tissue repair and promote functional tissue formation. The human acellular dermal matrix AlloDerm is widely used; however, it is offered at a relatively high cost, and its dermal composition may not provide an ideal remodeling scaffold. OviTex Plastic and Reconstructive Surgery (PRS) Resorbable and Permanent are reinforced biologic matrices engineered with layers of ovine forestomach matrix embroidered with small amounts of polymer to optimize biophysical performance. This study compared the healing outcomes of these matrices in a non-human primate model of soft tissue repair.</p><p><strong>Methods: </strong>Animals were implanted with test articles in surgically created full-thickness midline abdominal wall defects and evaluated macroscopically and histologically at 2, 4, 12, and 24 weeks.</p><p><strong>Results: </strong>Both OviTex PRS Permanent and Resorbable matrices exhibited earlier host cell infiltration, neovascularization, and collagen deposition and also fully remodeled into the host tissue by 12 weeks post implantation. AlloDerm had less host cell infiltration and neovascularization at early time points and never fully integrated into the surrounding host tissue. There was no statistical difference in overall inflammation between AlloDerm and either OviTex PRS product at any time point, despite small amounts of polymer reinforcement in OviTex products.</p><p><strong>Conclusions: </strong>In a primate soft tissue repair model, OviTex PRS Permanent and Resorbable matrices performed comparably with the leading human acellular dermal matrix. OviTex PRS Permanent and Resorbable are less expensive than alternatives like AlloDerm and may promote faster host cell proliferation and functional remodeling in some soft tissue repair applications.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e43"},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490877/pdf/eplasty-22-e43.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33486599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of Readmission Following Pediatric Hand Surgery: An Analysis of 6600 Patients. 小儿手部手术后再次入院的发生率:对 6600 名患者的分析
Pub Date : 2022-09-07 eCollection Date: 2022-01-01
Christopher J Goodenough, Cassie A Hartline, Shuyan Wei, Joseph K Moffitt, Alfredo Cepeda, Phuong D Nguyen, Matthew R Greives

Background: Quality in surgical outcomes is frequently assessed by the 30-day readmission rate. There are limited data available in the published literature regarding readmission rates following pediatric hand surgery. This study aims to identify factors associated with an increased risk of readmission following hand surgery in a pediatric population.

Methods: The 2012-2017 National Surgical Quality Improvement Project - Pediatric (NSQIP-P) databases were queried for pediatric patients who underwent procedures with hand-specific current procedural terminology (CPT) codes. The primary outcome was readmission.

Results: A total of 6600 pediatric patients were identified and included in the analysis. There were 45 patients who were readmitted in the study cohort, giving an overall readmission rate of 0.68%. The median time to readmission was 12 (IQR 5-20) days. On univariate analysis, factors associated with readmission included younger age, smaller size, prematurity, higher American Society of Anesthesiologists (ASA) class, inpatient admission at index operation, and longer anesthesia and operative times. Complex syndactyly repair was also associated with higher readmission rates. On multivariate analysis, ASA class 3 or 4 and inpatient surgery remained significant predictors of readmission.

Conclusions: Overall, pediatric hand surgery is associated with a very low risk of 30-day readmission. Higher ASA class and inpatient surgery increase patients' risk for readmission. In particular, complex syndactyly repair is associated with a higher risk of readmission than other hand procedures. This information is useful in surgical planning and preoperative counseling of parents.

背景:手术效果的质量经常通过 30 天再入院率来评估。有关小儿手部手术后再入院率的公开文献数据有限。本研究旨在确定小儿手部手术后再入院风险增加的相关因素:方法:对2012-2017年国家外科质量改进项目-儿科(NSQIP-P)数据库中接受手部手术的儿科患者进行了查询,这些患者接受的手术具有手部特定的当前程序术语(CPT)代码。主要结果是再入院率:共有 6600 名儿科患者被确认并纳入分析。研究队列中有 45 名患者再次入院,总再次入院率为 0.68%。再入院时间的中位数为 12 天(IQR 5-20 天)。单变量分析显示,与再入院相关的因素包括年龄较小、体型较小、早产、美国麻醉医师协会(ASA)分级较高、手术时住院以及麻醉和手术时间较长。复杂的联合畸形修复也与较高的再入院率有关。在多变量分析中,ASA 3级或4级和住院手术仍是再入院的重要预测因素:总体而言,小儿手部手术的 30 天再入院风险很低。结论:总体而言,小儿手部手术的 30 天再入院风险很低,但 ASA 分级较高和住院手术会增加患者的再入院风险。尤其是复杂的联合畸形修复术比其他手部手术的再入院风险更高。这些信息有助于制定手术计划和为家长提供术前咨询。
{"title":"Incidence of Readmission Following Pediatric Hand Surgery: An Analysis of 6600 Patients.","authors":"Christopher J Goodenough, Cassie A Hartline, Shuyan Wei, Joseph K Moffitt, Alfredo Cepeda, Phuong D Nguyen, Matthew R Greives","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Quality in surgical outcomes is frequently assessed by the 30-day readmission rate. There are limited data available in the published literature regarding readmission rates following pediatric hand surgery. This study aims to identify factors associated with an increased risk of readmission following hand surgery in a pediatric population.</p><p><strong>Methods: </strong>The 2012-2017 National Surgical Quality Improvement Project - Pediatric (NSQIP-P) databases were queried for pediatric patients who underwent procedures with hand-specific current procedural terminology (CPT) codes. The primary outcome was readmission.</p><p><strong>Results: </strong>A total of 6600 pediatric patients were identified and included in the analysis. There were 45 patients who were readmitted in the study cohort, giving an overall readmission rate of 0.68%. The median time to readmission was 12 (IQR 5-20) days. On univariate analysis, factors associated with readmission included younger age, smaller size, prematurity, higher American Society of Anesthesiologists (ASA) class, inpatient admission at index operation, and longer anesthesia and operative times. Complex syndactyly repair was also associated with higher readmission rates. On multivariate analysis, ASA class 3 or 4 and inpatient surgery remained significant predictors of readmission.</p><p><strong>Conclusions: </strong>Overall, pediatric hand surgery is associated with a very low risk of 30-day readmission. Higher ASA class and inpatient surgery increase patients' risk for readmission. In particular, complex syndactyly repair is associated with a higher risk of readmission than other hand procedures. This information is useful in surgical planning and preoperative counseling of parents.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e40"},"PeriodicalIF":0.0,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490882/pdf/eplasty-22-e40.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33486649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of Implant Malposition in Latissimus Dorsi Myocutaneous Flap Breast Reconstruction Using an Acellular Dermal Matrix With Pectoralis Muscle Following Mastectomy for Breast Cancer: A Clinical Review. 乳房切除术后胸肌脱细胞真皮基质胸阔肌肌皮瓣乳房重建预防假体错位的临床回顾。
Pub Date : 2022-09-06 eCollection Date: 2022-01-01
Milind D Kachare, Brooke E Barrow, Samuel Corey, Omar Elfanagely, Alexander J Rossi, Alyssa M Simpson, Swapnil D Kachare, Joshua Choo, Bradon J Wilhelmi

Background: Latissimus dorsi myocutaneous (LDM) pedicled flaps are a well-established method for breast reconstruction in women with inadequate soft tissue coverage following mastectomy for breast cancer. The robust nature of the latissimus blood supply can accommodate immediate implant placement to increase breast volume; however, a known risk factor with this technique is implant malposition. By utilizing an acellular dermal matrix (ADM) in subpectoral implant-based LDM reconstruction, it is hypothesized that patients will experience a lower incidence of implant malposition. This 13-year retrospective review aims to evaluate the effectiveness of breast reconstruction using this technique.

Methods: A retrospective review was conducted to identify all patients who underwent breast reconstruction following mastectomy with a LDM flap, subpectoral implant, and an ADM from 2007 to 2020 by a single surgeon at a single institution. Demographic and clinical data were collected and analyzed.

Results: A total of 40 patients (LDM flaps, N = 51) were identified. Mean participant age was 50.25 ± 9.67 years and mean body mass index (BMI) was 30.85 ± 6.15 kg/m2. Comorbidities included hypertension (40.0%), diabetes mellitus (17.5%), and current smoking (25.0%). Mean follow-up was 31.52 ± 29.51 months. The most common complication was seroma formation (9.8%). No patients experienced implant malposition or flap necrosis.

Conclusions: The use of a LDM flap and an ADM in implant-based breast reconstruction are each well described in the literature. This 13-year series supports the efficacy of these techniques utilized in combination to provide an aesthetic result while mitigating implant malposition during breast reconstruction of oncologic patients.

背景:背阔肌肌皮瓣是乳腺癌切除后软组织覆盖不足的女性乳房重建的一种行之有效的方法。阔肌血液供应的健壮性可以适应立即植入植入物以增加乳房体积;然而,使用这种技术的一个已知的危险因素是种植体错位。通过使用脱细胞真皮基质(ADM)在胸下植入物为基础的LDM重建中,假设患者将经历较低的植入物错位发生率。这13年的回顾性研究旨在评估使用该技术进行乳房重建的有效性。方法:回顾性分析2007年至2020年由同一医院的同一位外科医生在乳房切除术后进行LDM皮瓣、胸下植入物和ADM重建的所有患者。收集和分析人口统计学和临床资料。结果:共发现LDM皮瓣40例(51例)。平均年龄为50.25±9.67岁,平均体重指数(BMI)为30.85±6.15 kg/m2。合并症包括高血压(40.0%)、糖尿病(17.5%)和目前吸烟(25.0%)。平均随访31.52±29.51个月。最常见的并发症是血肿形成(9.8%)。无种植体错位或皮瓣坏死。结论:LDM瓣和ADM瓣在假体乳房重建中的应用在文献中都有很好的描述。这13年的研究结果支持了这些技术结合使用的有效性,在肿瘤患者乳房重建过程中提供了美观的结果,同时减少了植入物的错位。
{"title":"Prevention of Implant Malposition in Latissimus Dorsi Myocutaneous Flap Breast Reconstruction Using an Acellular Dermal Matrix With Pectoralis Muscle Following Mastectomy for Breast Cancer: A Clinical Review.","authors":"Milind D Kachare,&nbsp;Brooke E Barrow,&nbsp;Samuel Corey,&nbsp;Omar Elfanagely,&nbsp;Alexander J Rossi,&nbsp;Alyssa M Simpson,&nbsp;Swapnil D Kachare,&nbsp;Joshua Choo,&nbsp;Bradon J Wilhelmi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Latissimus dorsi myocutaneous (LDM) pedicled flaps are a well-established method for breast reconstruction in women with inadequate soft tissue coverage following mastectomy for breast cancer. The robust nature of the latissimus blood supply can accommodate immediate implant placement to increase breast volume; however, a known risk factor with this technique is implant malposition. By utilizing an acellular dermal matrix (ADM) in subpectoral implant-based LDM reconstruction, it is hypothesized that patients will experience a lower incidence of implant malposition. This 13-year retrospective review aims to evaluate the effectiveness of breast reconstruction using this technique.</p><p><strong>Methods: </strong>A retrospective review was conducted to identify all patients who underwent breast reconstruction following mastectomy with a LDM flap, subpectoral implant, and an ADM from 2007 to 2020 by a single surgeon at a single institution. Demographic and clinical data were collected and analyzed.</p><p><strong>Results: </strong>A total of 40 patients (LDM flaps, N = 51) were identified. Mean participant age was 50.25 ± 9.67 years and mean body mass index (BMI) was 30.85 ± 6.15 kg/m<sup>2</sup>. Comorbidities included hypertension (40.0%), diabetes mellitus (17.5%), and current smoking (25.0%). Mean follow-up was 31.52 ± 29.51 months. The most common complication was seroma formation (9.8%). No patients experienced implant malposition or flap necrosis.</p><p><strong>Conclusions: </strong>The use of a LDM flap and an ADM in implant-based breast reconstruction are each well described in the literature. This 13-year series supports the efficacy of these techniques utilized in combination to provide an aesthetic result while mitigating implant malposition during breast reconstruction of oncologic patients.</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"e39"},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490880/pdf/eplasty-22-e39.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33486600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Red Breast Syndrome: Complete Resolution Following Replacement of Acellular Dermal Matrices With Acellular Collagen Matrices. 红乳综合征:用脱细胞胶原基质替代脱细胞真皮基质后完全解决。
Pub Date : 2022-09-06 eCollection Date: 2022-01-01
Alyssa M Simpson, Brooke E Barrow, Samuel L Corey, Milind D Kachare, Joshua H Choo, Bradon J Wilhelmi

What is red breast syndrome (RBS)?What causes RBS?How often do patients present with RBS?What are effective treatments for RBS?

什么是红乳综合征(RBS)?是什么导致了苏格兰皇家银行?患者多久出现一次RBS?苏格兰皇家银行的有效治疗方法是什么?
{"title":"Red Breast Syndrome: Complete Resolution Following Replacement of Acellular Dermal Matrices With Acellular Collagen Matrices.","authors":"Alyssa M Simpson,&nbsp;Brooke E Barrow,&nbsp;Samuel L Corey,&nbsp;Milind D Kachare,&nbsp;Joshua H Choo,&nbsp;Bradon J Wilhelmi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>What is red breast syndrome (RBS)?What causes RBS?How often do patients present with RBS?What are effective treatments for RBS?</p>","PeriodicalId":11687,"journal":{"name":"Eplasty","volume":" ","pages":"QA1"},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615911/pdf/eplasty-22-QA1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40680322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eplasty
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1